Published in Tissue Antigens on December 01, 2004
A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet (2006) 1.55
HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes. Immunogenetics (2006) 0.89
HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia. J Immunol Res (2014) 0.81
Relationship between HLA-G polymorphism and susceptibility to recurrent miscarriage: a meta-analysis of non-family-based studies. J Assist Reprod Genet (2013) 0.81
Role of 14-bp deletion/insertion polymorphism in exon 8 of the HLA-G gene in recurrent spontaneous abortion patients. J Hum Reprod Sci (2011) 0.80
Association of the maternal 14-bp insertion/deletion polymorphism in the histocompatibility leukocyte antigen G gene with recurrent implantation failure. Iran J Reprod Med (2014) 0.79
HLA allele associations in idiopathic recurrent spontaneous abortion patients from India. J Hum Reprod Sci (2008) 0.77
HLA-G polymorphism (rs16375) and acute rejection in liver transplant recipients. Dis Markers (2014) 0.77
Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation. Front Immunol (2011) 0.77
The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors. Blood Transfus (2013) 0.75
Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation. F1000Res (2017) 0.75
Detection of nucleic acid hybridization by nonradiative fluorescence resonance energy transfer. Proc Natl Acad Sci U S A (1988) 4.90
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J (1997) 4.53
Efficient methods for attaching non-radioactive labels to the 5' ends of synthetic oligodeoxyribonucleotides. Nucleic Acids Res (1986) 4.12
Sequence identity of the n-1 product of a synthetic oligonucleotide. Nucleic Acids Res (1995) 3.88
Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A (1988) 2.85
SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob Agents Chemother (2006) 2.75
Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates. Proc Natl Acad Sci U S A (1988) 2.09
Chronic hepatitis B virus carriers have low lymphoproliferative responses to HBsAg and reduced interleukin-2 synthesis. Indian J Gastroenterol (1998) 2.03
Laparoscopic assisted transversus abdominis plane block: a novel insertion technique during laparoscopic nephrectomy. Anaesthesia (2011) 1.98
Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int (2008) 1.97
Barriers to treatment: why alcohol and drug abusers delay or never seek treatment. Addict Behav (1993) 1.93
Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol (1996) 1.87
Hepatitis E virus infection among animals in northern India: an unlikely source of human disease. J Viral Hepat (2007) 1.85
Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromuscul Disord (1999) 1.83
A prospective study of conventional transbronchial needle aspiration: performance and cost utility. Respiration (2010) 1.66
Is there any justification for the routine histological examination of straightforward cholecystectomy specimens? Ann R Coll Surg Engl (2007) 1.64
Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg (1993) 1.62
Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse. Lupus (2009) 1.60
Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment. Proc Natl Acad Sci U S A (1992) 1.59
Local anaesthesia: to warm or alter the pH? A survey of current practice. J R Coll Surg Edinb (1999) 1.58
Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides. Proc Natl Acad Sci U S A (1996) 1.58
Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study. Int J Tuberc Lung Dis (2004) 1.58
The association between narcolepsy and REM behavior disorder (RBD). Sleep Med (2005) 1.56
Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int J Obes (Lond) (2008) 1.54
Are patients who undergo open-access endoscopy more anxious about their procedures than patients referred from the GI clinic? Am J Gastroenterol (1996) 1.53
Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity. Nucleic Acids Res (1993) 1.53
Cross-cultural evaluation of two drinking assessment instruments: alcohol timeline followback and inventory of drinking situations. Subst Use Misuse (2001) 1.53
Ocular myocysticercosis: an unusual case of ptosis. Nepal J Ophthalmol (2013) 1.47
A regulatory RNA (PrrB RNA) modulates expression of secondary metabolite genes in Pseudomonas fluorescens F113. J Bacteriol (2000) 1.45
GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS. Antisense Res Dev (1992) 1.45
Use of parenteral methotrexate significantly reduces the need for biological therapy. Rheumatology (Oxford) (2007) 1.43
High expression of transforming growth factor-beta long cell cycle times and a unique clustering of S-phase cells in patients with acute promyelocytic leukemia. Blood (1992) 1.42
Use of transillumination technique for venous cannulation in paediatric patients under anaesthesia. Singapore Med J (2010) 1.41
Immunoproliferative small intestinal disease: a frequently missed diagnosis. Indian J Gastroenterol (1996) 1.41
The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol (2000) 1.40
Zosteriform and disseminated lesions in cutaneous leiomyoma. Acta Derm Venereol (2001) 1.40
Percutaneous treatment of catheter-induced dissection of the left main coronary artery and adjacent aortic wall: a case report. Catheter Cardiovasc Interv (2000) 1.35
Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan. Bull World Health Organ (2001) 1.34
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci U S A (1998) 1.30
Alcohol abusers who want to quit smoking: implications for clinical treatment. Drug Alcohol Depend (1999) 1.27
A comparison of a brief and long version of the Situational Confidence Questionnaire. Behav Res Ther (2000) 1.27
Nuclear transport of human DDB protein induced by ultraviolet light. J Biol Chem (2000) 1.23
Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways. J Neurochem (2001) 1.23
A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection. J Viral Hepat (2003) 1.20
Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth. J Biol Chem (1999) 1.20
Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. Proc Natl Acad Sci U S A (1993) 1.19
Seasonal distribution in conceptions achieved by artificial insemination by donor. BMJ (1988) 1.18
Large-scale synthesis, purification, and analysis of oligodeoxynucleotide phosphorothioates. Antisense Res Dev (1994) 1.17
Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol (1996) 1.17
Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J Immunol (2000) 1.17
Knowledge, attitudes and practices regarding tuberculosis among immigrants of Somalian ethnic origin in London: a cross-sectional study. Commun Dis Public Health (2004) 1.16
Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J Cardiol (1996) 1.16
Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J Immunol (2000) 1.15
Does Entamoeba histolytica cause irritable bowel syndrome? Indian J Gastroenterol (1997) 1.15
Heat shock protein 70 prevents secretagogue-induced cell injury in the pancreas by preventing intracellular trypsinogen activation. J Clin Invest (2000) 1.15
Primer premier: program for design of degenerate primers from a protein sequence. Biotechniques (1998) 1.14
Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res Dev (1994) 1.14
Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant (2004) 1.13
In vivo studies with antisense oligonucleotides. Trends Pharmacol Sci (1997) 1.12
TM Finder: a prediction program for transmembrane protein segments using a combination of hydrophobicity and nonpolar phase helicity scales. Protein Sci (2001) 1.12
Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms. Clin Cancer Res (2001) 1.12
Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol (2000) 1.12
Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A (1999) 1.09
Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani. Clin Exp Immunol (2005) 1.08
Benign esophageal stricture following aluminium phosphide poisoning. Indian J Gastroenterol (2006) 1.08
High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang (2003) 1.08
Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev (1997) 1.08
Retinal complications associated with hyperviscosity in chronic lymphocytic leukaemia. Intern Med J (2008) 1.08
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum. Proc Natl Acad Sci U S A (1992) 1.07
Fostering self-change among problem drinkers: a proactive community intervention. Addict Behav (1997) 1.06
Colocalization of centromeric and replicative functions on autonomously replicating sequences isolated from the yeast Yarrowia lipolytica. Proc Natl Acad Sci U S A (1993) 1.05
Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol (1996) 1.04
In vivo stability, disposition and metabolism of a "hybrid" oligonucleotide phosphorothioate in rats. Biochem Pharmacol (1995) 1.04
Single-strand-targeted triplex formation: stability, specificity and RNase H activation properties. Gene (1994) 1.03
Bone mass in Indian children--relationships to maternal nutritional status and diet during pregnancy: the Pune Maternal Nutrition Study. J Clin Endocrinol Metab (2006) 1.03
Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant (1994) 1.03
Improvement in the synthesis of oligonucleotides of extended length by modification of detritylation step. Nucleic Acids Res (1994) 1.03
Pharmacokinetics, biodistribution, and stability of capped oligodeoxynucleotide phosphorothioates in mice. Antisense Res Dev (1993) 1.02
Hydrogen peroxide tooth-whitening (bleaching) products: review of adverse effects and safety issues. Br Dent J (2006) 1.02
T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J Viral Hepat (2007) 1.01
Sequencing of synthetic oligonucleotides and analogs by homopolymeric tailing. Nucleic Acids Res (1995) 1.01
An evaluation of densitometric vertebral fracture assessment in men. Osteoporos Int (2007) 1.01
Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2 expression. Mol Med (1999) 1.00
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. Proc Natl Acad Sci U S A (1994) 1.00
New methods for assessing T-cell responses. Clin Diagn Lab Immunol (2000) 1.00
Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1. Biochem Pharmacol (1995) 1.00
Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages. Hum Reprod (2009) 0.99
Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity. Bioorg Med Chem Lett (1999) 0.99
A novel four-dimensional radiotherapy method for lung cancer: imaging, treatment planning and delivery. Phys Med Biol (2006) 0.98
Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy. Clin Exp Immunol (2009) 0.98
Is repeated coronary surgery for recurrent angina cost effective? Eur Heart J (1992) 0.98
Method for sequencing synthetic oligodeoxynucleotide phosphorothioates. Anal Biochem (1993) 0.98
Viral metagenomics reveal blooms of anelloviruses in the respiratory tract of lung transplant recipients. Am J Transplant (2014) 0.98
Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG. Vaccine (2001) 0.98
Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity. Bioorg Med Chem Lett (2000) 0.97
Partial allelotype of schistosomiasis-associated bladder cancer. Int J Cancer (1999) 0.97
Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. Clin Radiol (2012) 0.97
Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice. Antisense Nucleic Acid Drug Dev (1998) 0.97